However, the data of CRP and LRG, a new biomarker [ 16 ], showed a trend toward improvement, as did the patient’s clinical symptoms.
← all excerpts
Granulocyte and monocyte apheresis therapy for patients with active ulcerative colitis associated with COVID-19: a case report.
1
—
—